Hiroko Endo

1PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 07, 2026
Docirbrutinib is a pan-mutant BTK inhibitor and inhibits B-cell receptor signaling in chronic lymphocytic leukemia cells in preclinical and early clinical investigations.

Pageof 1

Frequent Collaborators

1 joint publications

Natalia Timofeeva

1 joint publications

Kyoko Miyamoto

1 joint publications

Masaaki Sawa

1 joint publications

Varsha Gandhi